Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
4.56 USD | -3.18% | +2.00% | +172.81% |
09/04 | Transcript : ADC Therapeutics SA - Special Call | |
04/04 | Sector Update: Health Care Stocks Slump Late Afternoon | MT |
Business Summary
Number of employees: 274
Sales per Business
USD in Million | 2022 | Weight | 2023 | Weight | Delta |
---|---|---|---|---|---|
Antibody Drug Conjugates
100.0
%
| 210 | 100.0 % | 70 | 100.0 % | -66.86% |
Managers
Managers | Title | Age | Since |
---|---|---|---|
Ameet Mallik
CEO | Chief Executive Officer | 51 | 09/22/09 |
Jose Carmona
DFI | Director of Finance/CFO | 51 | 19/22/19 |
Mohamed Zaki
CTO | Chief Tech/Sci/R&D Officer | 59 | 03/23/03 |
Chief Tech/Sci/R&D Officer | 55 | 01/12/01 | |
Chief Tech/Sci/R&D Officer | 69 | 01/22/01 | |
Corporate Officer/Principal | 51 | 17/22/17 | |
Kimberly Pope
HRO | Human Resources Officer | 57 | 17/20/17 |
Peter J. Graham
LAW | General Counsel | 57 | 01/22/01 |
Members of the board
Members of the board | Title | Age | Since |
---|---|---|---|
Peter Hug
BRD | Director/Board Member | 65 | 01/19/01 |
Ron Squarer
CHM | Chairman | 57 | 01/20/01 |
Jean Bizzari
BRD | Director/Board Member | 69 | 01/22/01 |
Ameet Mallik
CEO | Chief Executive Officer | 51 | 09/22/09 |
Victor Sandor
BRD | Director/Board Member | 57 | 27/20/27 |
Robert Azelby
BRD | Director/Board Member | 56 | 14/23/14 |
Thomas Pfisterer
BRD | Director/Board Member | 42 | 01/16/01 |
Tyrell J. Rivers
BRD | Director/Board Member | 51 | 01/18/01 |
Viviane Monges
BRD | Director/Board Member | 60 | 11/21/11 |
Share class
Vote | Quantity | Free-Float | Company-owned shares | Total Float | |
---|---|---|---|---|---|
Stock A | 1 | 89,562,809 | 62,947,767 ( 70.28 %) | 6,748,809 ( 7.535 %) | 70.28 % |
Company contact information
Sector
Sales per region
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
+172.81% | 390M | |
-0.94% | 104B | |
+6.11% | 97.47B | |
+5.71% | 22.25B | |
-13.38% | 21.68B | |
-9.70% | 18.2B | |
-39.98% | 17.02B | |
-10.05% | 16.36B | |
+8.44% | 14.39B | |
+39.71% | 12.37B |
- Stock Market
- Equities
- ADCT Stock
- Company ADC Therapeutics SA